Lista de obras - Mircea Balasa - Dominio Público Uruguay

A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index

artículo científico publicado en 2012

A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.

artículo científico publicado en 2011

A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease

artículo científico publicado en 2013

Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer's Disease.

artículo científico publicado en 2015

CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study

artículo científico publicado en 2016

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

artículo científico publicado en 2017

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

artículo científico publicado en 2015

Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease

artículo científico publicado en 2014

Clinical and neuropathological variability in clinically isolated central nervous system Whipple's disease

artículo científico publicado en 2014

Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment

scientific article published on 28 March 2019

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.

artículo científico publicado en 2011

Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.

artículo científico publicado en 2013

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

artículo científico publicado en 2020

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

artículo científico publicado en 2017

Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia

artículo científico publicado en 2013

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort

artículo científico publicado en 2014

Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints

artículo científico publicado en 2010

Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.

artículo científico publicado en 2012

Evolving brain structural changes in PSEN1 mutation carriers.

artículo científico publicado en 2014

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

artículo científico publicado en 2014

Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain

artículo científico publicado en 2017

Large APP locus duplication in a sporadic case of cerebral haemorrhage

artículo científico publicado en 2014

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

scientific article published on July 2016

PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.

artículo científico publicado en 2012

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

artículo científico publicado en 2015

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.

artículo científico

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study

artículo científico publicado en 2013

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

artículo científico publicado en 2017

Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.

artículo científico publicado en 2014

White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease

artículo científico publicado en 2016

White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels

artículo científico publicado en 2014

Lista de obras de Mircea Balasa

A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index

A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.

A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease

Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer's Disease.

CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study

Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease

Clinical and neuropathological variability in clinically isolated central nervous system Whipple's disease

Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease.

Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort

Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints

Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.

Evolving brain structural changes in PSEN1 mutation carriers.

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain

Large APP locus duplication in a sporadic case of cerebral haemorrhage

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.

White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease

White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels